• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov18
Whitehawk Therapeutics Reveals Its Antibody-Drug Conjugate Pipeline in Corporate Presentation
11:41
Nov7
Whitehawk Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 33.33 M), actual EPS USD -0.26 (forecast USD 0.0666)
04:00
Whitehawk Therapeutics released FY2025 9 Months Earnings on November 6 (EST), with actual revenue of USD 7.145 M and actual EPS of USD 0.8083
04:00
Nov6
Whitehawk Therapeutics Inc. Reports Q3 Net Loss and Updates R&D Progress
13:05
Oct24
Whitehawk Therapeutics Announces New Data on PTK7 and Plans to Submit Clinical Trial Application
16:30
Aug8
Whitehawk Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 33.33 M), actual EPS USD -0.7616 (forecast USD 0.4933)
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -17.75 M, EPS -0.26

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -52.62 M, EPS -0.7616

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.145 M, Net Income 73.02 M, EPS 1.8299

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
31.500
+370.85%
+24.810
HXHX
1.290
+273.91%
+0.945
SIDU
2.290
+97.41%
+1.130
MGRT
12.440
+70.41%
+5.140
MENS
4.780
+50.55%
+1.605
HYMC
24.520
+49.33%
+8.100
VELO
15.590
+43.95%
+4.760
QBTX
51.760
+39.25%
+14.590
CMCT
4.310
+35.11%
+1.120
FLYT
22.750
+32.81%
+5.620
View More